# FDA Clears First Over-the-Counter Continuous Glucose Monitor for Kids
The FDA has approved the first over-the-counter continuous glucose monitor designed for children, expanding access to real-time blood sugar tracking without requiring a prescription. This approval removes a significant barrier for families managing diabetes in young people.
Continuous glucose monitors, or CGMs, clip onto the skin and measure glucose levels throughout the day. They send readings to a smartphone or receiver every few minutes. Previously, all CGMs required a doctor's prescription and were primarily used by people with type 1 diabetes or insulin-dependent type 2 diabetes.
This OTC option changes the landscape for pediatric diabetes management. Parents can now purchase the device directly from pharmacies or online retailers without visiting a doctor first. For families in rural areas or those without easy access to endocrinologists, this removes a real obstacle.
The device works the same way as prescription models. A small sensor attaches to the back of the arm or abdomen and tracks glucose in interstitial fluid, which closely mirrors blood sugar levels. The data streams to a connected app, letting parents and children see patterns and make quick decisions about food, activity, and insulin doses.
Accessibility matters here. Diabetes in children often goes undiagnosed. The CDC reports that about 210,000 Americans under 20 have diagnosed diabetes, but many more may have prediabetes. An OTC monitor could help families identify blood sugar patterns earlier and prompt conversations with their pediatricians.
Parents should understand that having a CGM doesn't replace regular doctor visits or A1C blood tests. These devices measure current glucose but don't diagnose diabetes. An OTC monitor works best when families combine it with medical advice.
Cost remains a consideration. Many insurance plans cover prescription CGMs for diagnosed diabetic patients. OTC pricing typically runs $75 to $100